bioshares report, page-83

"When money starts coming in CZD will increase in price. Until then it is another speculative biotech. All the speculative section of the market is struggling as investors are risk intolerant."

BG, I can point you to many examples where biotech companies have had massive increases in share price and they have no money coming in either...and they are much more speculative than CZD. It's not accurate to say all speculative sections of the market are struggling....These is plenty money and plenty risk tolerance in many areas, particular tech and biotech.

The simple reality is that there is absolutely no interest in this company and there is plenty interest in others